Novasep launches Merck-tested BioSC Pilot for batch and continuous chromatography

By Flora Southey contact

- Last updated on GMT

Novasep's BioSC Pilot
Novasep's BioSC Pilot
Novasep has launched a downstream processing tool that combines batch and continuous chromatography for monoclonal antibodies, recombinant proteins and blood factors.

Novasep’s BioSC Pilot – a chromatography and downstream processing skid – is designed to purify biomolecules for early pilot phase to small commercial production.

“Its distinctive characteristic is that these chromatography steps can be combined with intermediate steps such as buffer preparation and viral inactivation by pH adjustment,” ​a spokesperson told us.

“This multi-step chaining leads to an intensified process with drastically improved performance: shorter processing time, increased yield, reduced footprint, and better product quality and operator safety,” ​she added.

According to the firm, the BioSC Pilot – which can perform both batch and continuous chromatography – was developed in response to industry demand for a “flexible solution that combines batch and continuous chromatography at pilot scale.”

A partnership with Merck KGaA, based in Germany, ensured the BioSC Pilot was tested and validated to meet market needs, the spokesperson continued: “In parallel, interest for the BioSC Pilot concept was validated with several Novasep customers in the biopharmaceutical industry.”

The BioSC Pilot follows on from the Novasep’s BioSC Lab, which launched three years ago. The technology purified ‘a few grams’ of protein daily – either in continuous, batch, or in parallel batch models, we were told.

“With BioSC Pilot, Novasep is supporting its customers for the scale-up of their purification processes to pilot scale and up to small commercial production,” ​the spokesperson explained.

Last month​, Novasep announced plans to invest €10m ($11.88m) in a commercial fill/finish facility for viral vectors, monoclonal antibodies (mAbs), and low-volume biologics, in Seneffe, Belgium.

Related news

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...


Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Related suppliers

Follow us


View more